𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Low molecular weight IgM in cytomegalovirus infections and cardiac patients

✍ Scribed by J. Nagington; D. J. Smith; M. P. Cranage


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
478 KB
Volume
10
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

When 71 ischaemic heart disease and cardiomyopathy patients' sera were examined by the IFA (indirect fluorescent antibody) test, 18 of the 49 (36%) with CMV (cytomegalovirus) CF antibody appeared to contain a specific LMW (7S approx) IGM.

This IgM was unrelated to the presence of RF (rheumatoid factor) demonstrable by agglutination of IgG‐coated latex and by an immunofluorescence test, was not absorbed by heat‐aggregated IgG and latex, nor did its demonstration appear to be complement dependent. It was demonstrable in acute CMV infection and in some cardiac patients, binds to HSV (herpes simplex virus) and CMV‐infected cells.


πŸ“œ SIMILAR VOLUMES


Low molecular weight heparin stimulates
✍ Or, Reuven; Elad, Sharon; Shpilberg, Ofer; Eldor, Amiram πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 205 KB πŸ‘ 2 views

The use of low molecular weight heparin (LMWH) as prophylaxis for veno-occlusive disease of the liver has been studied in patients undergoing bone marrow transplantation (BMT). The present study analyzes the effect of LMWH on the time course of platelet recovery after BMT. Significantly accelerated

Unfractionated- versus low-molecular-wei
✍ Gilles L. Fraser; Richard R. Riker πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 47 KB

I n the pharmacoeconomic evaluation of enoxaparin versus un- fractionated heparin (UFH) for the prevention of venous thrombosis in medical patients, Leykum et al. 1 concluded that lowmolecular-weight heparin (LMWH) offered greater cost utility. This important benefit was based on a single advantage